These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25620567)

  • 1. Clinical and Sociodemographic Factors Associated With Attention-Deficit/Hyperactivity Disorder in Patients With Cystic Fibrosis.
    Eworuke E; Zeng QY; Winterstein AG
    Psychosomatics; 2015; 56(5):495-503. PubMed ID: 25620567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Adverse Childhood Experiences and ADHD Diagnosis and Severity.
    Brown NM; Brown SN; Briggs RD; Germán M; Belamarich PF; Oyeku SO
    Acad Pediatr; 2017; 17(4):349-355. PubMed ID: 28477799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
    Karic S; DesRosiers M; Mizrahi B; Zevallos J; Rodriguez P; Barengo NC
    Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study.
    Connor DF; Ford JD
    J Clin Psychiatry; 2012 May; 73(5):711-7. PubMed ID: 22697195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.
    Chung W; Jiang SF; Paksarian D; Nikolaidis A; Castellanos FX; Merikangas KR; Milham MP
    JAMA Netw Open; 2019 Nov; 2(11):e1914344. PubMed ID: 31675080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder in school-aged children: association with maternal mental health and use of health care resources.
    Lesesne CA; Visser SN; White CP
    Pediatrics; 2003 May; 111(5 Pt 2):1232-7. PubMed ID: 12728144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(44):1439-43. PubMed ID: 21063274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient-centered medical home, practice patterns, and functional outcomes for children with attention deficit/hyperactivity disorder.
    Toomey SL; Chan E; Ratner JA; Schuster MA
    Acad Pediatr; 2011; 11(6):500-7. PubMed ID: 21967721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis.
    Cohen-Cymberknoh M; Tanny T; Breuer O; Blau H; Mussaffi H; Kadosh D; Gartner S; Salinas A; Bentur L; Nir V; Gur M; Reiter J; Shoseyov D; Kerem E; Berger I
    J Cyst Fibros; 2018 Mar; 17(2):281-285. PubMed ID: 29269187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of pyrethroid pesticide exposure with attention-deficit/hyperactivity disorder in a nationally representative sample of U.S. children.
    Wagner-Schuman M; Richardson JR; Auinger P; Braun JM; Lanphear BP; Epstein JN; Yolton K; Froehlich TE
    Environ Health; 2015 May; 14():44. PubMed ID: 26017680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
    dosReis S; Owens PL; Puccia KB; Leaf PJ
    Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
    Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma in patients with attention-deficit/hyperactivity disorder: a nationwide population-based study.
    Tsai CJ; Chou PH; Cheng C; Lin CH; Lan TH; Lin CC
    Ann Clin Psychiatry; 2014 Nov; 26(4):254-60. PubMed ID: 25401712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM; McIntyre RS; Park YM
    J Clin Psychiatry; 2014 Nov; 75(11):e1278-83. PubMed ID: 25470092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
    Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
    Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.